Financial Performance - The company's revenue for Q1 2020 was ¥634,283,585.15, a decrease of 33.33% compared to ¥951,424,447.25 in the same period last year[8] - The net profit attributable to shareholders was -¥121,844,721.30, representing a decline of 126.38% from -¥53,822,598.25 year-over-year[8] - Basic and diluted earnings per share were both -¥0.16, down 128.57% from -¥0.07 in the same quarter last year[8] - Operating income decreased by 33.33% year-on-year, attributed to a decline in market prices of viscose products, changes in the scope of consolidation, and the impact of the pandemic[16] - Total operating revenue for Q1 2020 was CNY 425.71 million, a decrease of 57.4% compared to CNY 1,000.10 million in the same period last year[41] - Operating profit for Q1 2020 was a loss of CNY 133.71 million, compared to a loss of CNY 105.02 million in Q1 2019[39] - Net profit for Q1 2020 was a loss of CNY 125.97 million, compared to a loss of CNY 106.14 million in the same period last year[39] - Total operating costs for Q1 2020 were CNY 760.86 million, down from CNY 1,013.01 million in the previous year[39] Cash Flow - The net cash flow from operating activities was -¥262,259,246.41, a significant drop of 237.82% compared to ¥190,287,700.15 in the previous year[8] - Cash received from operating activities decreased by 42.29% year-on-year, mainly due to a decline in market prices of viscose products and changes in the scope of consolidation[16] - Other cash received related to operating activities decreased by 30.16% year-on-year, primarily due to a reduction in the recovery of restricted cash[16] - Cash inflow from operating activities for Q1 2020 was CNY 705.82 million, compared to CNY 1,132.99 million in the same period last year[44] - The net cash flow from operating activities was -262,259,246.41 CNY, compared to 190,287,700.15 CNY in the previous period, indicating a significant decline in operational cash generation[46] - Total cash inflow from financing activities was 1,445,574,252.60 CNY, while cash outflow was 1,016,324,033.76 CNY, resulting in a net cash flow of 429,250,218.84 CNY[47] - Cash inflow from operating activities totaled 1,485,185,659.23 CNY, while cash outflow was 1,298,254,825.76 CNY, leading to a net cash flow of 186,930,833.47 CNY[49] - The company recorded a net cash flow from investment activities of -221,279,220.99 CNY, reflecting increased investment expenditures[50] Assets and Liabilities - Total assets increased by 12.38% to ¥7,133,146,177.78 from ¥6,347,388,953.83 at the end of the previous year[8] - The net assets attributable to shareholders decreased by 8.63% to ¥1,289,482,670.86 from ¥1,411,327,392.16 at the end of the previous year[8] - Current liabilities totaled CNY 4,798,462,350.23, up from CNY 4,053,927,701.84, representing a growth of 18.3%[31] - Non-current liabilities increased to CNY 1,018,719,934.51 from CNY 851,526,235.12, marking a rise of 19.6%[31] - The company's total liabilities reached CNY 5,817,182,284.74, compared to CNY 4,905,453,936.96, an increase of 18.6%[31] - Total current assets as of March 31, 2020, amounted to CNY 3,215,315,876.93, compared to CNY 2,387,826,683.41 at the end of 2019[29] Shareholder Information - The top shareholder, Aoyang Group Co., Ltd., holds 32.24% of the shares, with 250,349,599 shares pledged[11] - The total number of ordinary shareholders at the end of the reporting period was 57,763[11] Research and Development - Research and development expenses decreased by 93.57% year-on-year, mainly due to a reduction in investment in viscose product R&D[16] - Research and development expenses for Q1 2020 were CNY 1.21 million, significantly lower than CNY 18.86 million in Q1 2019[39] Government Support - The company received government subsidies amounting to ¥6,934,568.32 during the reporting period[9] Other Financial Metrics - The weighted average return on equity was -9.02%, a decline of 6.08% compared to -2.94% in the same period last year[8] - The company reported an investment income of CNY 3.67 million for Q1 2020[39] - Financial expenses for Q1 2020 were CNY 45.54 million, an increase from CNY 25.53 million in Q1 2019[39] - Other income for Q1 2020 was CNY 380.27 million, down from CNY 2.37 million in the previous year[39] Audit and Standards - The company did not undergo an audit for the first quarter report[52] - The company did not apply new revenue and leasing standards for the current period[51]
澳洋健康(002172) - 2020 Q1 - 季度财报